You have 9 free searches left this month | for more free features.

Red Blood Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Large B-cell Lymphoma Trial in Shanghai (BZ019)

Recruiting
  • Large B-cell Lymphoma
  • BZ019
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Jul 21, 2022

Peripheral Artery Disease Trial in Omaha (Supervised exercise therapy)

Not yet recruiting
  • Peripheral Artery Disease
  • Supervised exercise therapy
  • Omaha, Nebraska
    Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Aug 24, 2023

Large B-cell Lymphoma Trial in Groningen (89Zr-atezolizumab PET-imaging)

Recruiting
  • Large B-cell Lymphoma
  • 89Zr-atezolizumab PET-imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 15, 2022

Treatment Side Effects Trial (the Mandarin Version of the electronic patient self-Reporting of Adverse-events (eRAPID-MV), the

Not yet recruiting
  • Treatment Side Effects
  • the Mandarin Version of the electronic patient self-Reporting of Adverse-events (eRAPID-MV)
  • the telephone triage decision support system (TTDSS)
  • (no location specified)
Aug 9, 2022

Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

Not yet recruiting
  • Advanced Solid Tumors Cancer
  • +3 more
  • New York, New York
    Memorial Slone Kettering Cancer Center
Jun 26, 2023

Bronchial Dysplasia, Tobacco Smoking, History of NSCLC Trial in Aurora, Denver (Nivolumab)

Recruiting
  • Bronchial Dysplasia
  • +3 more
  • Aurora, Colorado
  • +1 more
Nov 4, 2021

Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

Recruiting
  • Metastatic Squamous Non-Small Cell Lung Carcinoma
  • Cabozantinib 40 MG
  • Pembrolizumab 200mg
  • Chicago, Illinois
    University of Illinois at Chicago
Jan 20, 2023

Ridge Splitting Trial in Mansoura (ridge splitting with implant placement)

Completed
  • Ridge Splitting
  • ridge splitting with implant placement
  • Mansoura, Dakahlia, Egypt
    Marwa Adel
Apr 19, 2023

Sickle Cell Disease Trial in Afula (Memantine Hydrochloride)

Unknown status
  • Sickle Cell Disease
  • Memantine Hydrochloride
  • Afula, Israel
    Emek Medical Centre
Oct 30, 2019

Esophageal Cancer in Northeastern Iran

Active, not recruiting
  • Esophageal Cancer
  • GI Disease
    • Tehran, Iran, Islamic Republic of
      Digestive Disease Research Institute
    Aug 18, 2022

    The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT Trial (CD25

    Not yet recruiting
    • The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
    • CD25 prophylaxis
    • (no location specified)
    Jun 20, 2023

    Brain Neuronal Networks, Chemosensory and Trigeminal Functions

    Recruiting
    • Hematopoietic Stem Cell Transplantation
      • Oslo, Norway
        University of Oslo
      Aug 21, 2023

      Type 1 Diabetes Trial in Stanford, Aurora, Charlottesville (Tandem t:slim X2 with Control-IQ Technology Pro, Standard Care (SC),

      Completed
      • Type 1 Diabetes
      • Tandem t:slim X2 with Control-IQ Technology Pro
      • +2 more
      • Stanford, California
      • +2 more
      Oct 7, 2022

      Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Portland (Ibrutinib, Obinutuzumab)

      Completed
      • Recurrent Mantle Cell Lymphoma
      • Refractory Mantle Cell Lymphoma
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Dec 10, 2021

      Aging Trial in Boulder (MitoQ, Placebo)

      Recruiting
      • Aging
      • MitoQ
      • Placebo
      • Boulder, Colorado
        University of Colorado Boulder
      Jul 20, 2022

      Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)

      Completed
      • Tuberculosis, Multidrug-Resistant
      • Beijing, China
      • +7 more
      Sep 30, 2021

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

      Recruiting
      • Hepatitis B, Chronic
      • Vancouver, British Columbia, Canada
      • +31 more
      Jan 17, 2023

      Clear Cell Renal Cell Carcinoma, First-line Treatment Trial in Shanghai (AK104, axitinib)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • First-line Treatment
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Feb 16, 2022

      Repeat Immunoadsorption Post Covid ME/CFS

      Recruiting
      • Post-COVID ME/CFS
      • IA with TheraSorb ® column
      • Berlin, Germany
        Charité - Universitätsmedizin Berlin
      Nov 21, 2022

      miRNAs Associated With Gender Difference in Osteoarthritis

      Recruiting
      • Osteoarthritis
      • No intervention
      • Bagheria, Palermo, Italy
        Dipartimento Rizzoli Sicilia - Istituto Ortopedico Rizzoli
      Aug 31, 2022

      Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma Trial in New York (Nivolumab, Atezolizumab, Radiation &

      Terminated
      • Metastatic Renal Cell Carcinoma
      • Metastatic Urothelial Carcinoma
      • New York, New York
        Weill Cornell Medicine - New York Presbyterian Hospital
      Aug 26, 2021

      Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • Santiago De Compostela, A Coruña, Spain
      • +29 more
      Sep 21, 2022

      Combat Injury on Sleep and Cardiovascular Outcomes

      Not yet recruiting
      • Hypertension
      • +5 more
        • (no location specified)
        Jul 24, 2023

        MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

        Recruiting
        • Myelodysplastic Syndromes
        • Unrelated Umbilical Cord Blood
        • +3 more
        • Hefei, Anhui, China
          The First Affiliated Hospital of University of Science and Techn
        Oct 27, 2023

        Healthy Aging Trial in Reading (Watermelon Juice, Water)

        Active, not recruiting
        • Healthy Aging
        • Watermelon Juice
        • Water
        • Reading, UK, United Kingdom
          University of Reading
        Nov 15, 2022